Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
DYN
Stock Latest News
Press Releases
Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric Designations for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
13h ago
DYN
The Fly
Dyne Therapeutics granted orphan status for DMD treatment
2d ago
DYN
Press Releases
Dyne Therapeutics Announces Presentations on its DM1 and DMD Programs at the 2023 Muscular Dystrophy Association Clinical & Scientific Conference
4d ago
DYN
Press Releases
Dyne Therapeutics to Present at Upcoming Investor Conferences
16d ago
DYN
The Fly
Dyne Therapeutics price target raised to $20 from $17 at Chardan
21d ago
DYN
Press Releases
Dyne Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
21d ago
DYN
The Fly
Dyne Therapeutics expects cash to fund operations through 2024
21d ago
DYN
The Fly
Dyne Therapeutics reports Q4 EPS (74c), consensus (84c)
21d ago
DYN
The Fly
Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James
25d ago
DYN
RNA
The Fly
Oppenheimer starts Dyne Therapeutics at Outperform with $34 price target
1M ago
DYN
The Fly
Dyne Therapeutics initiated with an Outperform at Oppenheimer
1M ago
DYN
Stock Analysis & Ideas
TipRanks ‘Perfect 10’ List: Strong Catalysts Confirm the Bull Thesis on These 2 Stocks
2M ago
DYN
PRTA
The Fly
Dyne Therapeutics initiated with a Buy at Guggenheim
2M ago
DYN
Press Releases
Dyne Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
3M ago
DYN
The Fly
Dyne Therapeutics price target lowered to $18 from $24 at JPMorgan
4M ago
DYN
Press Releases
Dyne Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
5M ago
DYN
Press Releases
Dyne Therapeutics to Present at Investor Conferences in November
5M ago
DYN
Press Releases
Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
5M ago
DYN
Press Releases
Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress
5M ago
DYN
Press Releases
Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
6M ago
DYN
Press Releases
Dyne Therapeutics Highlights DM1 and DMD Clinical Programs During “Spotlight on the Clinic” Virtual Event
6M ago
DYN
Press Releases
Dyne Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
7M ago
DYN
Press Releases
Dyne Therapeutics Announces Initiation of Phase 1/2 ACHIEVE Clinical Trial of DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
7M ago
DYN
Press Releases
Dyne Therapeutics Appoints Francesco Bibbiani, M.D., as Senior Vice President, Head of Development
7M ago
DYN
Press Releases
Dyne Therapeutics Announces “Breakthrough Article” Publication of Duchenne Muscular Dystrophy Program Data in Nucleic Acids Research
8M ago
DYN
Press Releases
Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
8M ago
DYN
Press Releases
Dyne Therapeutics Announces FDA Clearance of IND Application for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
9M ago
DYN
Press Releases
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
10M ago
DYN
Stock Analysis & Ideas
Dyne Therapeutics on its Way to Clinical Stage
2y ago
DYN
NDX
You need to enable JavaScript to run this app.
